首页> 外国专利> NEW UNLABELLED AND RADIOACTIVE LABELLED DERIVATIVES OF BUTYLAMINO PROPIOPHENONE,THEIR PREPARATION,IMMUNOGENS OBTAINED FROM THE UNLABELLED DERIVATIVES AND A PROCESS FOR IMMUNOGEN PREPARATION ANTISERA RAISED USING THE IMMUNOGENS AND A METHOD FOR RAISING ANTISERA,A RADIOIMMUNOASSAY METHOD AND A TEST KIT FOR USE IN THE ASSAY METHOD

NEW UNLABELLED AND RADIOACTIVE LABELLED DERIVATIVES OF BUTYLAMINO PROPIOPHENONE,THEIR PREPARATION,IMMUNOGENS OBTAINED FROM THE UNLABELLED DERIVATIVES AND A PROCESS FOR IMMUNOGEN PREPARATION ANTISERA RAISED USING THE IMMUNOGENS AND A METHOD FOR RAISING ANTISERA,A RADIOIMMUNOASSAY METHOD AND A TEST KIT FOR USE IN THE ASSAY METHOD

机译:没药和放射性标记的丁胺普罗酮的衍生物,它们的制备,从未标记的衍生物中获得的免疫原以及使用免疫原和抗原的方法引起的免疫原制备抗癌的方法,使用该方法的方法以及使用该药物的方法是一种有效的方法。

摘要

A radioimmunoassay procedure has been discovered for bupropion [(+/-)-2-t-butylamino-3-chloropropiophenone], an antidepressant compound, in biological fluids. Novel compounds of formula IMAGE wherein either R2 is oxygen and R1 is (CH2)n-0-(CO)m-(CH2)p-COOH where n is an integer from 0 to 5, m is 0 or 1, and p is an integer from 1 to 4; or R1 is hydrogen and R2 is N-0-(CH2)q-COOH where q is an integer from 1 to 3, and novel methods of making them and novel intermediates useful therein are disclosed. Novel immunogens for raising bupropion specific antisera, and novel methods of making them are disclosed comprising conjugates of the novel compounds and suitable carrier material. The drug is added to the antisera together with novel radiolabeled competitor of formula IMAGE wherein R' is a suitable radioisotope as described above and R3 is hydrogen, R4 is Cl, and R5 is oxygen, or R' is hydrogen and either (a) R3 is H and R4 is Cl and R5 is NO(CH2)qCO-X where q is as defined for formula I and X is a group having formula III IMAGE III wherein R6 is a suitable radioisotope as described above, R7 is hydroxyl, and s is an integer from 1 to 4; (b) R4 is Cl, R5 is oxygen, and R3 is (CH2)n-0-(CO)m-(CH2)p-CO-X where n, m, and p are as defined for formula I and X is as defined above; or (c) R3 is hydroxy, R5 is oxygen and R4 is a suitable radioisotope as defined above. The measure of radioactivity of the antisera bound radiolabeled competitor provides a measure of the amount of drug in the assayed biological fluid sample. A standard curve can be constructed from which the amount of drug in the assay sample can be interpolated. A kit is disclosed for practicing the radioimmunoassay.
机译:已发现生物流体中安非他酮[(+/-)-2-t-丁基氨基-3-氯丙苯酮](一种抗抑郁化合物)的放射免疫分析方法。式的新型化合物,其中R 2是氧并且R 1是(CH 2)n-0-(CO)m-(CH 2)p -COOH,其中n是0至5的整数,m是0或1,并且p是1至4的整数;或R 1为氢且R 2为N-0-(CH 2)q -COOH,其中q为1至3的整数,并公开了制备它们的新方法和可用于其中的新型中间体。公开了用于产生安非他酮特异性抗血清的新型免疫原,以及制备它们的新方法,其包括所述新型化合物和合适的载体材料的缀合物。将药物与新型放射性标记的式竞争剂一起添加到抗血清中,其中R'是如上所述的合适的放射性同位素,R3是氢,R4是Cl,R5是氧,或R'是氢,并且(a )R3为H且R4为Cl且R5为NO(CH2)qCO-X,其中q如式I所定义,且X为具有式III的基团。其中R6为如上所述的合适的放射性同位素,R7为s为1至4的整数; (b)R4为Cl,R5为氧,R3为(CH2)n-0-(CO)m-(CH2)p-CO-X,其中n,m和p如式I所定义,X为如上定义; (c)R 3为羟基,R 5为氧,R 4为如上定义的合适的放射性同位素。抗血清结合的放射性标记的竞争者的放射性的量度提供了测定的生物流体样品中药物量的量度。可以构建标准曲线,从中可以插入分析样品中的药物量。公开了用于进行放射免疫测定的试剂盒。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号